Across the report, Ellie Sullivan says she wanted genetic testing for the breast cancer gene linked to her mother’s diagnosis and death. Her mother was diagnosed with breast cancer at age 42. Sullivan describes spending more than a decade seeking testing because of concerns she could develop the same disease. She says she was not offered genetic testing during that period and instead was only provided screening after she developed an aggressive tumour herself. The article frames her account as an example of what she says is a broader problem for other women in similar family circumstances, particularly those who seek earlier access to testing or screening based on relatives’ breast cancer histories. The reports do not add additional confirmed details beyond her personal account, such as specific genetic results, the criteria used for denial, or the clinical pathways involved, focusing instead on her experience of delayed testing and subsequent screening following her diagnosis. The account is presented as a firsthand description of how she says timelines for testing and screening affected her.